MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib

MicroRNA-423-5p Promotes Autophagy in Cancer Cells and Is Increased in Serum From Hepatocarcinoma Patients Treated With Sorafenib

Hepatocellular carcinoma (HCC) is the third cause of cancer-related deaths worldwide. Sorafenib is the only approved drug for patients with advanced HCC but has shown limited activity. microRNAs (miRs) have been involved in several neoplasms including HCC suggesting their use or targeting as good to...

Full description

Bibliographic Details
Main Authors: Paola Stiuso, Nicoletta Potenza, Angela Lombardi, Ida Ferrandino, Antonio Monaco, Silvia Zappavigna, Daniela Vanacore, Nicola Mosca, Filomena Castiello, Stefania Porto, Raffaele Addeo, Salvatore Del Prete, Ferdinando De Vita, Aniello Russo, Michele Caraglia
Format: Article
Language:English
Published: Elsevier 2015-01-01
Series:Molecular Therapy: Nucleic Acids
Subjects:
Autophagy
hepatocellular carcinoma
miRNA
prognosis
treatment
Online Access:http://www.sciencedirect.com/science/article/pii/S2162253116300191

Internet

http://www.sciencedirect.com/science/article/pii/S2162253116300191

Similar Items